IRIS - Res&Arch Institutional Research Information System - Research & Archive

PUXEDDU, Efisio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.219
EU - Europa 4.250
AS - Asia 3.738
SA - Sud America 738
Continente sconosciuto - Info sul continente non disponibili 324
AF - Africa 84
OC - Oceania 8
Totale 15.361
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.014
SG - Singapore 1.682
UA - Ucraina 725
IT - Italia 603
BR - Brasile 568
SE - Svezia 565
IE - Irlanda 522
RU - Federazione Russa 497
FR - Francia 496
CN - Cina 481
HK - Hong Kong 454
VN - Vietnam 426
DE - Germania 272
KR - Corea 213
FI - Finlandia 198
GB - Regno Unito 137
BD - Bangladesh 125
CA - Canada 84
IN - India 65
AR - Argentina 50
IQ - Iraq 42
MX - Messico 42
TR - Turchia 42
BE - Belgio 33
CO - Colombia 32
NL - Olanda 29
CH - Svizzera 28
PK - Pakistan 28
PL - Polonia 26
AT - Austria 25
EC - Ecuador 25
UZ - Uzbekistan 25
ID - Indonesia 22
SA - Arabia Saudita 21
ZA - Sudafrica 21
JP - Giappone 19
VE - Venezuela 17
ES - Italia 16
PY - Paraguay 15
RO - Romania 14
JM - Giamaica 12
SV - El Salvador 11
CL - Cile 10
CZ - Repubblica Ceca 10
GR - Grecia 10
IL - Israele 10
MA - Marocco 10
PH - Filippine 10
BG - Bulgaria 9
CR - Costa Rica 9
LB - Libano 9
MY - Malesia 9
EU - Europa 8
HN - Honduras 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
EE - Estonia 7
GT - Guatemala 7
KE - Kenya 7
TN - Tunisia 7
AU - Australia 6
EG - Egitto 6
KZ - Kazakistan 6
LT - Lituania 6
NI - Nicaragua 6
PR - Porto Rico 6
AO - Angola 5
DZ - Algeria 5
KG - Kirghizistan 5
NP - Nepal 5
OM - Oman 4
PA - Panama 4
SN - Senegal 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AL - Albania 3
AM - Armenia 3
BS - Bahamas 3
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
JO - Giordania 3
MD - Moldavia 3
PE - Perù 3
PT - Portogallo 3
QA - Qatar 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GA - Gabon 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LY - Libia 2
NG - Nigeria 2
PS - Palestinian Territory 2
Totale 15.021
Salva come PNG Salva come JPEG
Città #
Singapore 1.163
Chandler 721
San Jose 578
Dublin 522
Hong Kong 453
Ashburn 449
Jacksonville 404
San Mateo 285
Santa Clara 251
Dong Ket 243
Boardman 235
Council Bluffs 206
Seoul 194
Moscow 155
Medford 152
Princeton 152
Lauterbourg 142
Altamura 126
Perugia 122
Wilmington 122
Beijing 119
Ann Arbor 104
Lawrence 97
Andover 94
Piscataway 93
Los Angeles 91
New York 88
Munich 84
Ho Chi Minh City 65
Dallas 52
Rome 47
São Paulo 47
Hanoi 44
Woodbridge 40
Helsinki 39
Saint Petersburg 38
The Dalles 38
Des Moines 35
Phoenix 35
Brussels 33
Turku 28
Redmond 27
Shanghai 27
Auburn Hills 23
Falls Church 23
Milan 23
Orem 23
Chicago 22
North Bergen 22
London 20
Tashkent 20
Toronto 20
Chennai 19
Frankfurt am Main 19
Norwalk 19
Tokyo 19
Atlanta 18
Baghdad 18
San Paolo di Civitate 17
Houston 16
Naples 16
Denver 15
Montreal 15
Buffalo 14
Columbus 14
Johannesburg 14
Medellín 14
Brasília 13
Brooklyn 13
Curitiba 13
Nuremberg 13
Warsaw 13
Boston 12
Bucharest 12
Guangzhou 12
Lahore 12
Rio de Janeiro 12
Amsterdam 11
Belo Horizonte 11
Bologna 11
Charlotte 11
Da Nang 11
Philadelphia 11
Quito 11
San Francisco 11
San Salvador 11
Vienna 11
Mexico City 10
Redwood City 10
Falkenstein 9
Izmir 9
Lausanne 9
Dhaka 8
Fremont 8
Jeddah 8
Kingston 8
Washington 8
Karbala 7
Las Vegas 7
Recife 7
Totale 8.826
Salva come PNG Salva come JPEG
Nome #
A useful ultrasound score to select thyroid nodules requiring fine needle aspiration in an iodine-deficient area. 199
Aspirato con ago sottile dei noduli tiroidei: striscio convenzionale vs preparato in strato sottile. 178
Analisi del proteoma di carcinomi papillari della tiroide positivi per la mutazione BRAFV600E 163
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF). 161
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif 158
A usefull ultrasound score to select thyroid nodules requiring FNA in an iodine area 151
. Indoleamine 2,3-dioxygenase expression in papillary thyroid carcinoma : study of its correlation with tumor genetics and clinical behaviour 145
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation 144
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas. 141
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties. 140
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 140
Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon? 137
Analisi del meccanismo dominante inibitorio esercitato in cis dalle mutazioni inattivanti D594V e G596R sulla mutazione attivante di BRAF V600E 136
The role of BRAF V6ooE in regulating the expression of proangiogenic factors in papillary thyroid carcinomas : in vivo and in vitro analysis. 136
L’ecografia intraoperatoria nella chirurgia delle recidive del cancro differenziato della tiroide. 133
Search of ret/ptc rearrangement and braf and ras mutations in a umbrian papillary thyroid carcinoma cohort showed high prevalence of braf mutation and allowed to detect a new mutation of braf oncoprotein 133
Androgen Receptor Mutations in Prostate Cancer 131
Espressione di MKP-1 nei noduli iperplastici, adenomi e carcinomi papillari della tiroide. 130
B-RAF activating mutations inhibit genes related to intrathyroidal iodine metabolism in papillary thyroid carcinoma 129
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. 126
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer 125
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas 124
INSL4 as prognostic marker for proliferation and invasiveness in non-small-cell lung cancer 123
Etiopatogenesi dei carcinomi della tiroide che originano dall’epitelio follicolare 123
The Stone Guest: How Does pH Affect Binding Properties of PD-1/PD-L1 Inhibitors? 121
Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent Potency 120
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF 119
Analisi della espressione degli oncogeni RET/PTC e del proto-oncogene RET in una coorte di carcinomi papillari della tiroide sporadici e correlazione con le caratteristiche clinico-patologiche delle neoplasie 118
Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors 118
Proteomic analysis of papillary thyroid carcinoma reveals demodulation of mechanisms regulating cell proliferation, susceptibility to oxidative stress and cellular aggregation 117
Revisione della casistica dei pazienti affetti da oftalmopatia basedowiana seguiti presso il Dipartimento di Medicina Interna dell’Università degli Studi di Perugia negli anni 1990-2007 116
Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study 116
Medicina molecolare in chirurgia della tiroide 116
Caratterizzazione biochimica e molecolare della nuova mutazione BRAFV599Ins recentemente individuata in un carcinoma papillare della tiroide 116
Wnt/B-catenin activation and TP53 mutations associate with distinct immune profiles in advanced thyroid cancer 115
Fine needle aspiration cytology of thyroid nodules: conventional smears vs thin layer technique 115
Primitive thyroid lymphomas 115
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer 115
A combined approach for thyroid fine needle aspiration: liquid based cytology, cell block and immunohistochemical methods with the implementation of the Cellient™ automated cell block system 114
Molecular dynamic simulations of the catalytic domain of BRAF in response to activating and inactivating mutations 114
Severe spruelike enteropathy due to olmesartan 114
Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation 112
Anti-htert sirna-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 112
The aryl hydrocarbon receptor is expressed in thyroid carcinoma and appears to mediate epithelial-mesenchymal-transition 111
BRAF mutations and RET/PTC rearrangements in an italian thyroid tumor cohort 110
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif. 110
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. 107
L’analisi proteomica del carcinoma papillare della tiroide evidenzia modificazioni dello stato ossidoriduttivo e della struttura delle cellule tumorali 107
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer 107
Signal transducer and activator of transcription 1 plays a pivotal role in RET/PTC3 oncogene-induced expression of indoleamine 2,3-dioxygenase 1 106
Surgical treatment of sporadic medullary thyroid carcinoma: strategy and outcome. 105
Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma 105
INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IS UPREGULATED IN THYROID CARCINOMA AND DRIVES THE DEVELOPMENT OF AN IMMUNOSUPPRESSANT TUMOR MICROENVIRONMENT. 105
Clinical implications of BRAF mutation in thyroid carcinoma 104
I tumori della tiroide 103
Braf mutation testing in fnac samples increases accuracy of thyroid cytology in a region of high braf mutation prevalence 102
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 102
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors. 101
8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2) 101
B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. 100
Surgical treatment of primitive thyroid lymphoma 99
Liver alcoholic cirrhosis and spur-cell (acanthocytic) anaemia. A study of erythrocyte ghost composition and fluidity 99
Aspetti di biologia molecolare degli ipertiroidismi 99
Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens 98
Recurrence of thyroid well differentiated cancer: ultrasonography-guided surgical treatment 97
Immunohistochemical analisis of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in papillary thyroid carcinoma (PYC): a marker of lymph node metastasis. 97
Acromegaly is associated with increased cancer risk: a survey in Italy 97
Le sostituzioni aminoacidiche G596R e D594V hanno un effetto inibitorio dominante sulla funzione della mutazione V600E di BRAF 96
Epigenetics of thyroid cancer and novel therapeutic targets. 96
The 2009 American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: progress on the road from consensus- to evidence-based practice. 95
EFFETTO DI DUE INIBITORI CHINASICI IN LINEE CELLULARI DI CARCINOMA TIROIDEO: STUDI IN VITRO E IN VIVO 95
Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. 94
Patogenesi del carcinoma della tiroide 93
Surgical treatment of medullary thyroid carcinoma (MTC) 93
Germline BRAF mutations in Noonan, LEOPARD and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum 93
Conditional expression of RET/PTC3 in PCCL3 cells induces microsomal Prostaglandin E Synthase expression and Prostaglandin E2 biosynthesis through the activation of MEK-ERK pathway 92
La mutazione V599E dell’oncogene BRAF rappresenta l’alterazione genetica più frequente nei carcinomi papillari della tiroide sporadici dell’adulto 92
Surgical treatment of differenziated thyroid carcinoma: a retrospective study 92
Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas. 92
Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells 91
THERAPY of ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: From bench to bedside 91
Clinical prognosis in BRAF-mutated PTC 91
Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer. 90
Oncogeni e chirurgia della tiroide 89
Evaluation of goiter using ultrasound criteria: a survey in a middle schoolchildren population of a mountain area in Central Italy. 89
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 89
Molecular dynamic simulation of the catalytic domain of BRAF in response to activating and inactivating mutation 88
Diagnostic-therapeutic pathways as instruments of clinical management: experience at the S. Maria Hospital in Terni 88
Caratteristiche genetiche di una coorte di carcinomi papillari della tiroide raccolta in Umbria e loro significato clinico 88
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment 88
Ventilatory response to exercise in diabetic subjects with autonomic neuropathy 87
Confronto tra citologia aspirativa con ago sottile e parametri eco-color-doppler nei noduli tiroidei 87
Proteomic analysis of papillary thyroid carcinomas reveals demodulation of signal transduction pathways, increased resistance to oxidative stress and gain of invasive phenotype. 86
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 85
Comparison between fine needle aspiration cytology and ultrasound features in thyroid nodules: an US score to select thyroid nodules requiring FNA. 85
Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway 85
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 83
Lo studio dell’espressione genica indotta da RET/PTC nella linea cellulare PCCL3 evidenzia l’attivazione precoce di geni coinvolti nella regolazione della risposta immunitaria. 82
Isozyme-specific abnormalities of protein kinase C in thyroid cancer: evidence for epigenetic changes in PKC epsilon 82
Synthesis of phosphatidylserine by base exchange in rat cerebellum and cortex 82
Totale 11.030
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022961 0 0 0 113 31 8 18 397 6 49 139 200
2022/20232.106 179 394 30 193 178 206 2 110 710 21 68 15
2023/2024853 57 106 33 18 20 6 155 28 159 25 123 123
2024/20252.088 24 218 99 98 228 79 49 201 448 132 332 180
2025/20264.519 351 347 233 567 513 370 708 257 551 396 135 91
2026/20271.435 98 172 293 872 0 0 0 0 0 0 0 0
Totale 15.361